TERMIS 2021 | Treating keratoconus with tissue engineered corneas

Mark Daniell, MBBS, MS, FRANZCO, FRACS, Royal Victorian Eye and Ear Hospital & Centre for Eye Research Australia, Melbourne, Australia, provides an overview of the treatment landscape for keratoconus, a disorder that results in the thinning and bulging of the cornea. Corneal cross-linking increases corneal strength and prevents further disease progression; advancements in artificial intelligence has additionally enabled identifying cases of keratoconus earlier in patients, reducing the need for corneal transplants. Tissue engineered corneal stroma constructed from electrocompacted collagen represent a promising alternative treatment for keratoconus. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).